ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
0,00%
Bitcoin
69 334,48
0,00%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Faron Pharmaceuticals Oy (FARN)

  7. Faron Pharmaceuticals Oy (FARN) Actualités

FARN

Faron Pharmaceuticals Oy (FARN)

Faron Pharmaceuticals Oy
De:
Trier par:
 Showing the most relevant articles for your search:LSE:FARN
DateHeureSourceTitreSymboleSociété
05/06/202409h00RNS Regulatory NewsFaron Pharmaceuticals Oy Proposed REX Retail OfferLSE:FARNFaron Pharmaceuticals Oy
04/06/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron commences a share offeringLSE:FARNFaron Pharmaceuticals Oy
20/05/202410h03Alliance NewsAlliance NewsFaron Pharma celebrates positive read-out in ongoing MDS trialLSE:FARNFaron Pharmaceuticals Oy
20/05/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Initial positive data from Phase 2 of BEXMABLSE:FARNFaron Pharmaceuticals Oy
17/05/202417h00RNS Regulatory NewsFaron Pharmaceuticals Oy Issuance of warrantsLSE:FARNFaron Pharmaceuticals Oy
16/05/202408h05RNS Non-RegulatoryFaron Pharmaceuticals Oy Founders named European Inventor Award finalistsLSE:FARNFaron Pharmaceuticals Oy
13/05/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Replacement – Board ChangeLSE:FARNFaron Pharmaceuticals Oy
03/05/202414h39Alliance NewsAlliance NewsTRADING UPDATES: Kelso raises stake in NCC; Transense joins projectLSE:FARNFaron Pharmaceuticals Oy
30/04/202415h00RNS Regulatory NewsFaron Pharmaceuticals Oy Update on financial statusLSE:FARNFaron Pharmaceuticals Oy
30/04/202414h00RNS Regulatory NewsFaron Pharmaceuticals Oy Board ChangeLSE:FARNFaron Pharmaceuticals Oy
16/04/202408h00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron confirms plans under new leadershipLSE:FARNFaron Pharmaceuticals Oy
15/04/202411h58Alliance NewsAlliance NewsFaron Pharmaceuticals reappoints former finance chief on interim basisLSE:FARNFaron Pharmaceuticals Oy
15/04/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Financial OfficerLSE:FARNFaron Pharmaceuticals Oy
08/04/202412h50Alliance NewsAlliance NewsUPDATE: Faron Pharmaceuticals promotes COO to CEO as father retiresLSE:FARNFaron Pharmaceuticals Oy
08/04/202412h28Alliance NewsAlliance NewsFaron Pharmaceuticals promotes COO to CEO as founder steps backLSE:FARNFaron Pharmaceuticals Oy
08/04/202408h15Alliance NewsAlliance News*Faron Pharmaceuticals says Markku Jalkanen to retire as CEO in Q2 but remain board memberLSE:FARNFaron Pharmaceuticals Oy
08/04/202408h15Alliance NewsAlliance News*Faron Pharmaceuticals promotes COO Juho Jalkanen to CEO, starting May 1LSE:FARNFaron Pharmaceuticals Oy
08/04/202408h10RNS Regulatory NewsFaron Pharmaceuticals Oy Approval of Warrant Terms and ConditionsLSE:FARNFaron Pharmaceuticals Oy
08/04/202408h05RNS Regulatory NewsFaron Pharmaceuticals Oy Decisions of the Board of DirectorsLSE:FARNFaron Pharmaceuticals Oy
08/04/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Appointment of Chief Executive OfficerLSE:FARNFaron Pharmaceuticals Oy
05/04/202413h00RNS Regulatory NewsFaron Pharmaceuticals Oy Results of the Annual General MeetingLSE:FARNFaron Pharmaceuticals Oy
04/04/202412h58Alliance NewsAlliance NewsFaron Pharmaceuticals secures funding to deliver next "milestones"LSE:FARNFaron Pharmaceuticals Oy
04/04/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Announcement of PlacingLSE:FARNFaron Pharmaceuticals Oy
03/04/202411h59Alliance NewsAlliance NewsTRADING UPDATES: Quiz sales fall, names new CEO; Byotrol eyes AIM exitLSE:FARNFaron Pharmaceuticals Oy
28/03/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Issue of Warrants to IPF Funding UpdateLSE:FARNFaron Pharmaceuticals Oy
26/03/202411h00RNS Regulatory NewsFaron Pharmaceuticals Oy Faron´s Annual Report 2023LSE:FARNFaron Pharmaceuticals Oy
18/03/202418h09Alliance NewsAlliance NewsLONDON MARKET CLOSE: Stocks downbeat before central bank rate stormLSE:FARNFaron Pharmaceuticals Oy
18/03/202412h41Alliance NewsAlliance NewsFaron Pharmaceuticals shares jump on positive data from Bexmab studyLSE:FARNFaron Pharmaceuticals Oy
18/03/202408h00RNS Regulatory NewsFaron Pharmaceuticals Oy Additional Positive Data from Phase 1 of BEXMABLSE:FARNFaron Pharmaceuticals Oy
14/03/202408h00RNS Non-RegulatoryFaron Pharmaceuticals Oy Faron to Host BEXMAB WebcastLSE:FARNFaron Pharmaceuticals Oy
 Showing the most relevant articles for your search:LSE:FARN

Dernières Valeurs Consultées

LSE
AXN
Alexon
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés